Skip to main content
search
Category

Highlights Archive

HighlightsHighlights Archive

NHS Medium Term Planning Framework released

The NHS has published its Medium Term Planning Framework for 2026/27 to 2028/29 which sets out a 3-year roadmap to get the NHS back to its constitutional standards. This marks a shift away from the annual planning cycle, offering NHS organisations a three-year horizon to align reform, recovery and transformation. Diagnostics (alongside elective care and cancer) is a core performance…
Ben Kemp
October 28, 2025
HighlightsHighlights Archive

Government launches major R&D challenge on diagnosing dementia

Science Minister Lord Vallance has announced the launch of a major R&D challenge aiming to ensure 92% of patients are diagnosed with dementia within 18 weeks of referral by 2029. Diagnostic solutions identified include: accelerating work on blood tests that spot the build-up of proteins associated with dementia and developing saliva analysis which picks up hormone changes at the early…
Ben Kemp
October 28, 2025
HighlightsHighlights Archive

Media Monitoring: 16th – 22nd October

One in six bacterial infections worldwide are now resistant to antibiotics, WHO warns The World Health Organization (WHO) has warned of a sharp rise in antimicrobial resistance (AMR), with one in six bacterial infections worldwide now resistant to antibiotic treatments. WHO’s latest global surveillance report found that antibiotic resistance rose in over 40% of the pathogen-antibiotic combinations monitored from 2018…
Ben Kemp
October 21, 2025
HighlightsHighlights Archive

BIVDA provides Budget and Life Science Investment Inquiry submissions

In the last week, BIVDA have provided submissions to the Treasury ahead of the Budget on the 26th November and to the Commons' Science, Innovation and Technology Committee for their emergency inquiry into life sciences investment in the UK. The latter was prompted by high-profile withdrawals from the UK's life science sphere, notably Merck's recent decision to scrap a £1bn…
Ben Kemp
October 21, 2025
HighlightsHighlights Archive

Galleri test for 50 cancers yields exciting results in trial

The cutting-edge Galleri blood test, currently under evaluation by the NHS, has shown strong promise during a trial in detecting more than 50 types of cancer in people with no symptoms. In the US trial known as PATHFINDER 2, involving around 23,161 participants, the test found a “cancer signal” in 216 individuals and cancer was later confirmed in 133 of them,…
Ben Kemp
October 21, 2025
HighlightsHighlights Archive

Experts call for prostate cancer screening for men with BRCA1 and BRCA2 gene mutations

Prostate cancer guidelines should be updated so that all men aged 40 and over with BRCA1 or BRCA2 gene mutations are offered regular PSA testing, according to scientists at The Institute of Cancer Research (ICR), London. Their call follows new results from the international IMPACT study, which found that PSA screening detects more aggressive prostate cancers in men carrying BRCA1…
Ben Kemp
October 21, 2025
HighlightsHighlights Archive

Media Monitoring: 9th – 15th October

Nobel prize awarded for discovery of immune system’s ‘security guards’ Three scientists have been awarded the 2025 Nobel prize in physiology or medicine for discovering how the body stops its own immune system from turning against itself. Shimon Sakaguchi from Osaka University in Japan, Mary E. Brunkow from the Institute for System Biology and Fred Ramsdell from Sonoma Biotherapeutics, both…
Ben Kemp
October 15, 2025
HighlightsHighlights Archive

MHRA to deepen collaboration with US on regulation

The MHRA has outlined moves to deepen collaboration with the US on medical technology regulation, with initiatives to accelerate innovation, strengthen patient safety, and reduce transatlantic barriers to market access. At AdvaMed in San Diego, MHRA Chief Executive Lawrence Tallon highlighted the agency’s commitment to advancing global regulatory harmonisation and its strong partnership with the US Food and Drug Administration (FDA) during his fireside chat with Dr Michelle Tarver (Director, FDA…
Ben Kemp
October 14, 2025
Close Menu